LifePlan Financial Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$3K Buy
26
+23
+767% +$2.8K ﹤0.01% 514
2020
Q2
$0 Buy
+3
New +$115 ﹤0.01% 582

Other funds holding NVAX

LifePlan Financial Group's NVAX Position: Q3 2020 in Review

LifePlan Financial Group increased its Novavax (NVAX) stake by 767% in Q3 2020, buying an estimated $2.8K and bringing the position to 26 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #514.

LifePlan Financial Group first reported a position in NVAX in Q2 2020 and has held it in 2 quarters since. 311 funds tracked by Wall St. Rank hold NVAX as of Q3 2020.

  • LifePlan Financial Group held 26 shares of Novavax worth $3K as of Q3 2020.
  • LifePlan Financial Group bought 23 Novavax shares in Q3 2020, an estimated $2.8K.
  • Novavax made up ﹤0.01% of LifePlan Financial Group's portfolio in Q3 2020, its #514 holding.
  • LifePlan Financial Group first reported a position in Novavax in Q2 2020 and has held it in 2 quarters since.
  • 311 funds tracked by Wall St. Rank held Novavax as of Q3 2020.

Based on LifePlan Financial Group's 13F filing for Q3 2020, filed 30 Oct 2020.